The mitochondrion is an intracellular organelle thought to originate from endosymbiosis
between an ancestral eukaryotic cell and an α-proteobacterium. Mitochondria are the …

Recurrent thrombosis and miscarriages are the main clinical manifestations of
antiphospholipid syndrome (APS). Although most patients display both clinical signs, some …

Potentiation of neutrophil extracellular trap (NET) release is one mechanism by which
antiphospholipid antibodies (aPL Abs) effect thrombotic events in patients with …

Despite its potential to cause significant morbidity in children, pediatric antiphospholipid
syndrome (APS) is an understudied condition. In this review, we will cover what is known …

Objective Mitochondria are organelles that exhibit several bacterial features, such as a
double‐stranded genome with hypomethylated CpG islands, formylated proteins, and …

Background Antiphospholipid syndrome (APS) is an autoimmune disease characterized by
persistent antiphospholipid antibodies (aPLs) positivity with a wide manifestation spectrum …

Antiphospholipid antibody syndrome (APS) is a state of hypercoagulability secondary to an
autoimmune disorder. It is associated with thrombotic events in venous and arterial vessels …

Background Thrombotic antiphospholipid syndrome (t‐PAPS) is characterized by arterial,
venous, or microvascular occlusions, which are explained, in part, by the presence of …

Pediatric antiphospholipid syndrome (APS) is a rare acquired multisystem autoimmune
thromboinflammatory condition characterized by thrombotic and non-thrombotic clinical …

Background Non-criteria antiphospholipid antibodies (NC-aPL) are a relatively undefined
subgroup of antiphospholipid antibodies (aPL). Knowledge about NC-aPL in adults is …